169 filings
Page 5 of 9
8-K
i8v18xah2h
8 Jan 18
Regulation FD Disclosure
12:00am
8-K
ut9 nbd3dcm08
2 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
s2f1pox ulg
30 Nov 17
Intrexon Announces Key Management Appointments
12:00am
8-K
18294r8ks 8j0tvreq
9 Nov 17
Intrexon Announces Third Quarter 2017 Financial Results
12:00am
8-K
7nsd8iro
16 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
9we8hcp0yh
9 Aug 17
Intrexon Announces Second Quarter and First Half 2017 Financial Results
12:00am
8-K
1cx2kkey
30 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
3tazozi uwtzm
16 Jun 17
Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition
12:00am
8-K
eqknl9avcq6rzom
10 May 17
Intrexon Announces First Quarter 2017 Financial Results
12:00am
8-K
hcv4fno5qpxq8dk9u
27 Apr 17
Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors
12:00am
8-K
xy2751 7gd5qxknx1t
31 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
syrxzy7gv e6
10 Mar 17
Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets
12:00am
8-K
xcaziqqvqo3 36vp4mqs
1 Mar 17
Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
jrt67
24 Jan 17
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
12:00am
8-K
knwiplze386a
11 Jan 17
Regulation FD Disclosure
12:00am
8-K
tb255
30 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
e4ak8l7 771y
9 Nov 16
Intrexon Announces Third Quarter 2016 Financial Results
12:00am
8-K
cfdmb ggtm5ezfb2pfd1
3 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
huwfqv0a
9 Aug 16
Intrexon Announces Second Quarter and First Half 2016 Financial Results
12:00am
8-K
s8ptfi
8 Aug 16
Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer
12:00am